Investments
26Portfolio Exits
13Funds
8About BVCF
BVCF, formally known as BioVeda China Fund, is a growth capital focused private equity fund specializing in China Life Sciences and Healthcare industry. Headquartered in Shanghai, BVCF primarily focuses on equity investments in growth-stage companies in the field of Pharmaceuticals, Biotechnology, Traditional Chinese Medicine, Medical Devices, Healthcare Services, Industrial and Environmental Biotechnology.
Want to inform investors similar to BVCF about your company?
Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.
Latest BVCF News
Sep 22, 2022
NAMIBIA – Beef Value Chain Forum (BVCF), a consortium formed by Namibian beef producers, has raised an additional N$27.56 million (US$1.85m) to invest in a new beef export processing facility, known as Savanna Beef Processors Limited. The BVCF was officially inaugurated in 2021 with a growing membership base of over 500 members, with the aim…
BVCF Investments
26 Investments
BVCF has made 26 investments. Their latest investment was in Cellenkos as part of their Series A on November 11, 2021.
BVCF Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
11/4/2021 | Series A | Cellenkos | $15M | Yes | 7 | |
5/5/2021 | Series C | Oculis | $57M | Yes | 12 | |
2/9/2021 | Series B | Drug Farm | $56M | Yes | 11 | |
1/5/2021 | Series A | |||||
1/3/2021 | Series C |
Date | 11/4/2021 | 5/5/2021 | 2/9/2021 | 1/5/2021 | 1/3/2021 |
|---|---|---|---|---|---|
Round | Series A | Series C | Series B | Series A | Series C |
Company | Cellenkos | Oculis | Drug Farm | ||
Amount | $15M | $57M | $56M | ||
New? | Yes | Yes | Yes | ||
Co-Investors | |||||
Sources | 7 | 12 | 11 |
BVCF Portfolio Exits
13 Portfolio Exits
BVCF has 13 portfolio exits. Their latest portfolio exit was Oculis on March 03, 2023.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
|---|---|---|---|---|---|
3/3/2023 | Reverse Merger | 3 | |||
12/30/2022 | IPO | Public | 4 | ||
10/14/2022 | Acq - Pending | 3 | |||
Date | 3/3/2023 | 12/30/2022 | 10/14/2022 | ||
|---|---|---|---|---|---|
Exit | Reverse Merger | IPO | Acq - Pending | ||
Companies | |||||
Valuation | |||||
Acquirer | Public | ||||
Sources | 3 | 4 | 3 |
BVCF Acquisitions
1 Acquisition
BVCF acquired 1 company. Their latest acquisition was China Health System on December 18, 2006.
Date | Investment Stage | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Total Funding | Note | Sources |
|---|---|---|---|---|---|---|
12/18/2006 | Growth Equity | $120.1M | Leveraged Buyout | 1 |
Date | 12/18/2006 |
|---|---|
Investment Stage | Growth Equity |
Companies | |
Valuation | |
Total Funding | $120.1M |
Note | Leveraged Buyout |
Sources | 1 |
BVCF Fund History
8 Fund Histories
BVCF has 8 funds, including BVCF IV.
Closing Date | Fund | Fund Type | Status | Amount | Sources |
|---|---|---|---|---|---|
12/3/2018 | BVCF IV | Multi-Stage Venture Capital | Open | 3 | |
4/7/2014 | BioVeda China Fund III LP | ||||
4/4/2014 | BVCF III | ||||
4/15/2008 | BioVeda China Fund II LP | ||||
6/30/2005 | BioVeda China LP |
Closing Date | 12/3/2018 | 4/7/2014 | 4/4/2014 | 4/15/2008 | 6/30/2005 |
|---|---|---|---|---|---|
Fund | BVCF IV | BioVeda China Fund III LP | BVCF III | BioVeda China Fund II LP | BioVeda China LP |
Fund Type | Multi-Stage Venture Capital | ||||
Status | Open | ||||
Amount | |||||
Sources | 3 |
BVCF Team
4 Team Members
BVCF has 4 team members, including current Founder, Managing Partner, Zhi Yang.
Name | Work History | Title | Status |
|---|---|---|---|
Zhi Yang | Founder, Managing Partner | Current | |
Name | Zhi Yang | |||
|---|---|---|---|---|
Work History | ||||
Title | Founder, Managing Partner | |||
Status | Current |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.